| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 7224653
[patent_doc_number] => 20040072768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Inhibition of proliferation of cells'
[patent_app_type] => new
[patent_app_number] => 09/757555
[patent_app_country] => US
[patent_app_date] => 2001-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6435
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072768.pdf
[firstpage_image] =>[orig_patent_app_number] => 09757555
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/757555 | Inhibition of proliferation of cells | Jan 8, 2001 | Abandoned |
Array
(
[id] => 6656656
[patent_doc_number] => 20030077754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Methods and compositions for use in spliceosome mediated RNA trans-splicing'
[patent_app_type] => new
[patent_app_number] => 09/756096
[patent_app_country] => US
[patent_app_date] => 2001-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 62
[patent_figures_cnt] => 62
[patent_no_of_words] => 24872
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077754.pdf
[firstpage_image] =>[orig_patent_app_number] => 09756096
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/756096 | Methods and compositions for use in spliceosome mediated RNA trans-splicing | Jan 7, 2001 | Abandoned |
Array
(
[id] => 6934730
[patent_doc_number] => 20010056074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-27
[patent_title] => 'Novel lipophilic compounds having affinity with nucleic acids and therapeutical uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/754814
[patent_app_country] => US
[patent_app_date] => 2001-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8175
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20010056074.pdf
[firstpage_image] =>[orig_patent_app_number] => 09754814
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/754814 | Novel lipophilic compounds having affinity with nucleic acids and therapeutical uses thereof | Jan 3, 2001 | Abandoned |
Array
(
[id] => 1253829
[patent_doc_number] => 06670468
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-30
[patent_title] => '2-substituted nucleosides and oligonucleotide derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/753943
[patent_app_country] => US
[patent_app_date] => 2001-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22002
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670468.pdf
[firstpage_image] =>[orig_patent_app_number] => 09753943
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/753943 | 2-substituted nucleosides and oligonucleotide derivatives | Jan 2, 2001 | Issued |
Array
(
[id] => 6773858
[patent_doc_number] => 20030017196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Oligonucleotide inhibitors of bcl-xL'
[patent_app_type] => new
[patent_app_number] => 09/753169
[patent_app_country] => US
[patent_app_date] => 2001-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 9314
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017196.pdf
[firstpage_image] =>[orig_patent_app_number] => 09753169
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/753169 | Oligonucleotide inhibitors of bcl-xL | Jan 1, 2001 | Issued |
Array
(
[id] => 6894209
[patent_doc_number] => 20010016575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-23
[patent_title] => 'Antisense modulation of human MDM2 expression'
[patent_app_type] => new
[patent_app_number] => 09/752983
[patent_app_country] => US
[patent_app_date] => 2001-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17677
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20010016575.pdf
[firstpage_image] =>[orig_patent_app_number] => 09752983
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/752983 | Antisense modulation of human MDM2 expression | Jan 1, 2001 | Abandoned |
| 09/647586 | New compounds for DNA-Transfection | Dec 21, 2000 | Abandoned |
Array
(
[id] => 6555662
[patent_doc_number] => 20020111479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Process'
[patent_app_type] => new
[patent_app_number] => 09/740031
[patent_app_country] => US
[patent_app_date] => 2000-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2969
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20020111479.pdf
[firstpage_image] =>[orig_patent_app_number] => 09740031
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/740031 | Process | Dec 19, 2000 | Issued |
| 09/601997 | Non-bacterial cloning in delivery and expession of nucleic acids | Dec 14, 2000 | Abandoned |
Array
(
[id] => 1248413
[patent_doc_number] => 06673778
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-06
[patent_title] => 'Enzyme inhibitors for metabolic redirection'
[patent_app_type] => B1
[patent_app_number] => 09/737452
[patent_app_country] => US
[patent_app_date] => 2000-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 15345
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/673/06673778.pdf
[firstpage_image] =>[orig_patent_app_number] => 09737452
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/737452 | Enzyme inhibitors for metabolic redirection | Dec 12, 2000 | Issued |
Array
(
[id] => 5874605
[patent_doc_number] => 20020049173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Alteration of cellular behavior by antisense modulation of mRNA processing'
[patent_app_type] => new
[patent_app_number] => 09/734847
[patent_app_country] => US
[patent_app_date] => 2000-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 27219
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049173.pdf
[firstpage_image] =>[orig_patent_app_number] => 09734847
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/734847 | Alteration of cellular behavior by antisense modulation of mRNA processing | Dec 11, 2000 | Abandoned |
Array
(
[id] => 6876872
[patent_doc_number] => 20010007025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-05
[patent_title] => 'Antisense modulation of bcl-x expression'
[patent_app_type] => new-utility
[patent_app_number] => 09/734846
[patent_app_country] => US
[patent_app_date] => 2000-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 28812
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0007/20010007025.pdf
[firstpage_image] =>[orig_patent_app_number] => 09734846
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/734846 | Antisense modulation of bcl-x expression | Dec 11, 2000 | Abandoned |
Array
(
[id] => 4271968
[patent_doc_number] => 06307041
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-23
[patent_title] => 'Circular, hairpin, circular/hairpin, lariat, and hairpin-lariat hammerhead ribozymes'
[patent_app_type] => 1
[patent_app_number] => 9/647314
[patent_app_country] => US
[patent_app_date] => 2000-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 22
[patent_no_of_words] => 8949
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/307/06307041.pdf
[firstpage_image] =>[orig_patent_app_number] => 647314
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/647314 | Circular, hairpin, circular/hairpin, lariat, and hairpin-lariat hammerhead ribozymes | Dec 5, 2000 | Issued |
Array
(
[id] => 6888046
[patent_doc_number] => 20010009040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-19
[patent_title] => 'Fumonisin detoxification compositions and methods'
[patent_app_type] => new-utility
[patent_app_number] => 09/731393
[patent_app_country] => US
[patent_app_date] => 2000-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 20549
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20010009040.pdf
[firstpage_image] =>[orig_patent_app_number] => 09731393
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/731393 | Fumonisin detoxification compositions and methods | Dec 4, 2000 | Issued |
Array
(
[id] => 1454633
[patent_doc_number] => 06462184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-10-08
[patent_title] => 'Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds'
[patent_app_type] => B2
[patent_app_number] => 09/726096
[patent_app_country] => US
[patent_app_date] => 2000-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12698
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/462/06462184.pdf
[firstpage_image] =>[orig_patent_app_number] => 09726096
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/726096 | Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds | Nov 28, 2000 | Issued |
| 09/713017 | Retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell and elimination of unnecessary proviral sequences | Nov 15, 2000 | Abandoned |
Array
(
[id] => 623809
[patent_doc_number] => 07138518
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-11-21
[patent_title] => 'Liquid chromatographic separation of polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 09/714579
[patent_app_country] => US
[patent_app_date] => 2000-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 37
[patent_no_of_words] => 19412
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/138/07138518.pdf
[firstpage_image] =>[orig_patent_app_number] => 09714579
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/714579 | Liquid chromatographic separation of polynucleotides | Nov 15, 2000 | Issued |
| 09/712898 | Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes with immunomodulatory moieties | Nov 14, 2000 | Abandoned |
Array
(
[id] => 4311758
[patent_doc_number] => 06316422
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 9/706619
[patent_app_country] => US
[patent_app_date] => 2000-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 8599
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 258
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/316/06316422.pdf
[firstpage_image] =>[orig_patent_app_number] => 706619
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/706619 | Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof | Nov 5, 2000 | Issued |
| 09/702066 | Compositions and methods of synthesis and use of novel nucleic acid structures | Oct 29, 2000 | Abandoned |
